| Product Catalog： | B040036 |
| CAS No.： |
|
| Product Name： | Baloxavir Impurity 36 |
| Purity： | >95% HPLC |
| Synonyms: | (S)-12-((S)-7,8-difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-yl)-7-(hexyloxy)-3,4,12,12a-tetrahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione |
| Molecular Formula: | C30H31F2N3O4S |
| Mol. Weight： | 567.2 |
| Appearance: | White soild |
| Storage： | 2-8°C Refrigerator |
| Contact: | WhatsAPP: +86 17320513646
E-mail: anna@molcoo.com |
| Note: | We can also customize related analogues and modified peptides including HPLC, MS, 1H-NMR, MS, HPLC, IR, UV, COA, MSDS.
This product is intended for laboratory use only! |
| Background: | Baloxavir is a novel anti - influenza drug developed by Shionogi & Co., Ltd. in Japan. It is used to treat acute, uncomplicated influenza patients aged 12 and above and is effective against influenza viruses including type A and B, as well as oseltamivir - resistant influenza viruses. In the process of baloxavir synthesis, various impurities may be generated, such as process by - products and impurities introduced by raw materials. These impurities may affect the quality, safety, and efficacy of the drug, so the study of baloxavir impurities is of great significance for ensuring drug quality. |
China
